Surgery Partners Stock Current Valuation
| SGRY Stock | USD 25.80 0.69 2.60% |
Valuation analysis of Surgery Partners helps investors to measure Surgery Partners' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Surgery Partners' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 14.56 in 2024, whereas Enterprise Value is likely to drop slightly above 1.9 B in 2024. Fundamental drivers impacting Surgery Partners' valuation include:
Price Book 1.6775 | Enterprise Value 7.7 B | Enterprise Value Ebitda 13.8966 | Price Sales 1.2152 | Forward PE 23.6967 |
Fairly Valued
Today
Please note that Surgery Partners' price fluctuation is very steady at this time. Calculation of the real value of Surgery Partners is based on 3 months time horizon. Increasing Surgery Partners' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Surgery Partners is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgery Stock. However, Surgery Partners' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.8 | Real 26.24 | Target 46.78 | Hype 25.8 | Naive 25.75 |
The intrinsic value of Surgery Partners' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Surgery Partners' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Surgery Partners helps investors to forecast how Surgery stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgery Partners more accurately as focusing exclusively on Surgery Partners' fundamentals will not take into account other important factors: Surgery Partners Company Current Valuation Analysis
Surgery Partners' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Surgery Partners Current Valuation | 7.73 B |
Most of Surgery Partners' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Surgery Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Surgery Partners is extremely important. It helps to project a fair market value of Surgery Stock properly, considering its historical fundamentals such as Current Valuation. Since Surgery Partners' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgery Partners' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgery Partners' interrelated accounts and indicators.
Click cells to compare fundamentals
Surgery Current Valuation Historical Pattern
Today, most investors in Surgery Partners Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Surgery Partners' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Surgery Partners current valuation as a starting point in their analysis.
Surgery Partners Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Surgery Partners has a Current Valuation of 7.73 B. This is 46.18% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 53.5% higher than that of the company.
Surgery Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.Surgery Partners is currently under evaluation in current valuation category among its peers.
Surgery Partners ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Surgery Partners' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Surgery Partners' managers, analysts, and investors.Environmental | Governance | Social |
Surgery Fundamentals
| Return On Equity | 0.0476 | ||||
| Return On Asset | 0.04 | ||||
| Profit Margin | 0.0002 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 7.73 B | ||||
| Shares Outstanding | 127.09 M | ||||
| Shares Owned By Insiders | 1.09 % | ||||
| Shares Owned By Institutions | 98.91 % | ||||
| Number Of Shares Shorted | 9.71 M | ||||
| Price To Earning | 61.84 X | ||||
| Price To Book | 1.68 X | ||||
| Price To Sales | 1.22 X | ||||
| Revenue | 2.74 B | ||||
| Gross Profit | 574.9 M | ||||
| EBITDA | 526.6 M | ||||
| Net Income | (11.9 M) | ||||
| Cash And Equivalents | 227.4 M | ||||
| Cash Per Share | 2.58 X | ||||
| Total Debt | 3.06 B | ||||
| Debt To Equity | 1.44 % | ||||
| Current Ratio | 1.51 X | ||||
| Book Value Per Share | 15.57 X | ||||
| Cash Flow From Operations | 293.8 M | ||||
| Short Ratio | 8.96 X | ||||
| Earnings Per Share | 0.01 X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 41.09 | ||||
| Number Of Employees | 10.5 K | ||||
| Beta | 2.76 | ||||
| Market Capitalization | 3.23 B | ||||
| Total Asset | 7.02 B | ||||
| Retained Earnings | (569.2 M) | ||||
| Working Capital | 372 M | ||||
| Current Asset | 310.96 M | ||||
| Current Liabilities | 181.29 M | ||||
| Net Asset | 7.02 B |
About Surgery Partners Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.